Predicate |
Object |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-165 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C57-145 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C59-265 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-165 |
filingDate |
2014-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2016-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2016520628-A |
titleOfInvention |
Pharmaceutical formulation containing agomelatine in the form of agomelatine co-crystal with organic acid |
abstract |
The present invention is in the form of an agomelatin co-crystal with a co-crystal former selected from the group of organic acids, agomelatine corresponding to an amount of 15-22 mg agomelatin per dosage unit, and at least one pharmaceutically acceptable dosage. And a pharmaceutical formulation for the effective treatment of diseases responsive to treatment with agomelatine. |
priorityDate |
2013-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |